*  HOME INFUSION SERVICES IN ANCHORAGE PROFESSIONAL INFUSION PHARMACY ⋆ Geneva Woods Pharmacy, Health & Home Medical
HOME INFUSION SERVICES IN ANCHORAGE at our Professional Infusion Pharmacy is located at 501 W. International Airport Road, ... With training from our professional Home Infusion services team, patients and families can take an active role in all aspects ... We offer a comprehensive array of home infusion therapies from antibiotics and parenteral nutrition to chemotherapy and pain ... In-Suite Infusion. You can choose to receive your infusion treatments in our specially designed suites that provide warm, ...
  https://www.genevawoods.com/services/alaska/anchorage/home-infusion-services-in-anchorage-professional-infusion-pharmacy/
*  THE NATIONAL HOME INFUSION ASSOCIATION: Infusion Magazine - Archives
Counce J and Jurich S. Alternate-site infusion provider roundtable: A discussion of urgency-Why active grassroots is key to ... NHIA raises concerns on proposed Medicare policies for home parenteral nutrition. 1995;1(11):28-36. Rigas M. 340B drug pricing ... Our Current Issue Subscribe to INFUSION Author Guidelines Advertise in INFUSION Archives Faces Behind-the-Scenes CE Infusion ... Home infusion coding and claiming: Big changes are in the works. 2000;7(1):40-1. Kaplan LK. HIPAA, HIEC, and home infusion ...
  http://www.nhia.org/infusion/archives/regulatory.cfm
*  SODIUM CHLORIDE 0.18% AND GLUCOSE 4% INFUSION BP POLYFUSOR AS STERIFLEX NO. 18 OR FREEFLEX | Drugs.com
INFUSION BP POLYFUSOR AS STERIFLEX NO. 18 OR FREEFLEX Including dosage instructions and possible side effects. ... Active substance(s): GLUCOSE MONOHYDRATE FOR PARENTERAL USE / SODIUM CHLORIDE INJECTION. PDF options: View Fullscreen Download ... active ingredient can be seen in the name of product.. Sodium Chloride 0.9% and. Glucose 5% Solution for Infusion. What Sodium ... Infusion or you are given your infusion too quickly, this may lead to the following symptoms:. • water and/or sodium overload ...
  https://www.drugs.com/uk/sodium-chloride-0-18-and-glucose-4-infusion-bp-polyfusor-as-steriflex-no-18-or-freeflex-leaflet.html
*  Patent US7652001 - Pharmacologically active agents containing esterified phosphonates and ... - Google Patents
The percentage of active compound contained in such parenteral compositions is highly dependent on the specific nature thereof ... Illustratively, intravenous or intraarterial infusion of a sterile aqueous solution containing an active compound is an ... The active materials can also be mixed with other active materials which do not impair the desired action, or with materials ... To produce a prodrug, the pharmaceutically active compound is modified such that the active compound will be regenerated by ...
  http://www.google.com/patents/US7652001?dq=Xerox+%2B+%22centroid
*  Systemic administration of Hypocretin-1 - The Regents of the University of California
Hcrt-1 and other active agents of the invention can be formulated for parenteral administration by injection, e.g., by bolus ... The method of claim 6, wherein the dosage regime is administered by intravenous infusion. 14. The method of claim 6, wherein ... Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water-soluble ... Alternatively, the active ingredient can be in powder form for constitution with a suitable vehicle, e.g., sterile pyrogen-free ...
  http://www.freepatentsonline.com/7112566.html
*  Active principle | definition of active principle by Medical dictionary
... active principle explanation free. What is active principle? Meaning of active principle medical term. What does active ... Looking for online definition of active principle in the Medical Dictionary? ... is a potent dopamine agonist which in its parenteral forms (transdermal patch and sc infusion) has been developed to provide ... active. not passive.. active principle. the drugs or chemicals in a pharmaceutical preparation that exert an effect ...
  http://medical-dictionary.thefreedictionary.com/active+principle
*  Patente US7097827 - Devices, compositions and methods for the pulmonary delivery of aerosolized ... - Google Patentes
Suggested administration routes include parenteral by injection, rapid infusion, nasopharyngeal absorption, dermal absorption, ... Josic, Djuro, "Optimization of Process Conditions for the Production of Active Dry Yeast," Lebensm-Wiss, U. Technol., 1982, vol ... Townsend, Michael et al., "Use of Lyoprotectants in The Freez-Drying of a Model Protein Rebonuclease A," Journal of Parenteral ... Composition and method for administration of pharmaceutically active substances. US5017372. 19 Oct 1988. 21 May 1991. Medicis ...
  http://www.google.es/patents/US7097827?hl=es
*  Use of NPSP558 in the Treatment of Hypoparathyroidism - Full Text View - ClinicalTrials.gov
Patients dependent on regular parenteral calcium infusions (eg calcium gluconate) to maintain calcium homeostasis ... Subjects Who Achieved Independence from Active Vitamin D Usage and with Calcium Dose of 500 mg/day or less. This analysis was ... Proportion of Subjects Who Achieved Independence From Active Vitamin D and an Oral Calcium Dose of ≤ 500 mg/Day at Week 24. [ ... Patients that have undergone gastric resection or have active peptic ulcer disease requiring medical therapy ...
  https://clinicaltrials.gov/ct2/show/study/NCT00732615
*  Methods for detecting and treating cancer - The General Hospital Corporation
Alternatively, the active drug may be incorporated in biocompatible carriers, liposomes, nanoparticles, implants, or infusion ... Parenteral Compositions. The pharmaceutical composition may be administered parenterally by injection, infusion or implantation ... In one example, the first active anti-neoplasia therapeutic is contained on the inside of the tablet, and the second active ... Controlled Release Parenteral Compositions. Controlled release parenteral compositions may be in form of aqueous suspensions, ...
  http://www.freepatentsonline.com/9885720.html
*  2011 Oley Award and Scholarship Winners - Oley Foundation
Laurie is active with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) and the National Home Infusion ... Matisse is active in her school and once took on a project to collect extra Halloween candy to distribute to other children. ... Hardy, who is also active with PN-DU. Karen Winterbourn, who has known Brenda since 2009, says, "I have been amazed at Brenda's ... Brenda is a real presence in online support groups (such as Yahoo groups) and on the fairly new Parenteral Nutrition-Down Under ...
  http://oley.org/page/2011_Award_Winners/2011-Oley-Award-and-Scholarship-Winners.htm
*  US Patent # 4,119,717. 16-S-acyl derivatives of fusidic acid - Patents.com
For parenteral use the compounds are preferably given by intravenous infusion of an aqueous solution containing from 0.1 to 2 ... A preparation as claimed in claim 15 wherein the dosage unit contains from 0.2 g to 0.75 g of at least one active compound. 17 ... A parenteral pharmaceutical preparation in dosage unit form, containing from 0.05 g to 1 g of at least one compound according ... The parenteral preparations are in particular useful in the treatment of conditions in which a quick response to the treatment ...
  http://patents.com/us-4119717.html
*  Patent US6147109 - Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA ... - Google Patents
The term "parenteral" includes subcutaneous, intravenous, intramuscular, or infusion. Intravenous or intramuscular routes are ... Generally, doses of active compounds would be from about 0.01 mg/kg per day to 1000 mg/kg per day. It is expected that doses ... Physiologically active substances. US4231938 *. Jun 15, 1979. Nov 4, 1980. Merck & Co., Inc.. Hypocholesteremic fermentation ... Specific examples include, but are not limited to: (a) erosional systems in which the active compound is contained in a form ...
  http://www.google.com/patents/US6147109?dq=%22robert+sheehan%22
*  Patent US6180597 - Upregulation of Type III endothelial cell nitric oxide synthase by rho ... - Google Patents
The term "parenteral" includes subcutaneous, intravenous, intramuscular, or infusion. Intravenous or intramuscular routes are ... displaces an active protein from its interaction with the cellular machinery or competes with the active protein, thereby ... Generally, doses of active compounds would be from about 0.01 mg/kg per day to 1000 mg/kg per day. It is expected that doses ... Infusion Pumps and Methods for Use. US20070270581 *. 16 Nov 2005. 22 Nov 2007. Biomarin Pharmaceutical Inc.. Stable Tablet ...
  http://www.google.ca/patents/US6180597
*  Patent US8153162 - Purified amniotic membrane compositions and methods of use - Google Patents
Parenteral injections may involve bolus injection or continuous infusion. Formulations for injection may be presented in unit ... Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water soluble ... Parenteral Composition. A parenteral composition for intramuscular administration is prepared by mixing 10 mg each of: HA, TSG- ... Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration ...
  http://www.google.com/patents/US8153162?dq=7751826
*  US5312828A - Substituted imidazoles having angiotensin II receptor blocking activity - Google Patents
... or continuously by infusion. Oral dosage units for human administration preferably contain from 10 to 500 mg of active compound ... Preferably, lower dosages are used for parenteral administration. Oral administration, at higher dosages, however, also can be ... As a topical dosage unit form, an amount of active compound from between 50 ng to 0.05 mg, preferably 50 ng to 5 mg, is applied ... Topical formulations contain the active compound in an amount selected from 0.0001 to 0.1 (w/v%), preferably from 0.0001 to ...
  https://patents.google.com/patent/US5312828A/en
*  Patent US4532331 - 1-Benzyl-2-aminomethyl imidazole derivatives - Google Patents
... by injection or by infusion. Parenteral administration, which uses a low dose is preferred. However, oral administration, at a ... In addition to decreasing hypertension, inhibitors of NE synthesis are active as diuretics, natriuretics, cardiotonics and ... a nontoxic quantity selected from the range of 0.1-1,000 mg/kg of active compound, preferably 10-100 mg/kg. The selected dose ... to give the desired oral or parenteral end products. ...
  http://www.google.com/patents/US4532331?dq=6,970,917
*  Parenteral anesthesia | definition of parenteral anesthesia by Medical dictionary
What is parenteral anesthesia? Meaning of parenteral anesthesia medical term. What does parenteral anesthesia mean? ... Looking for online definition of parenteral anesthesia in the Medical Dictionary? parenteral anesthesia explanation free. ... Before nerve block anesthesia, an intravenous infusion is established to ensure hydration. The patient is protected with side ... The temperatures of elderly patients should be monitored, heat loss prevented, and, as necessary, active rewarming provided. ...
  https://medical-dictionary.thefreedictionary.com/parenteral+anesthesia
*  Patent US6492130 - Modulation of the sulfonylurea receptor and calcium in adipocytes for ... - Google Patents
... including parenteral, intranasal, intrapulmonar, oral, topical, anal or surgical implantation or insertion. Typical parenteral ... The pharmaceutically active agent can also be formulated in a sustained-release form to prolong the presence of the ... intraarterial and intraperitoneal injection or infusion. Preferably the administration is by injection. In preferred ... When pharmaceutically active agents are proteins, storage can be facilitated by drying processes, such as lyophilization. ...
  http://www.google.com/patents/US6492130?dq=6,123,819
*  US Patent # 9,670,198. Nicotinic acetylcholine receptor modulators - Patents.com
The percentage of active compound contained in such parenteral compositions is highly dependent on the specific nature thereof ... Illustratively, intravenous or intraarterial infusion of a sterile aqueous solution containing an active compound is an ... The percentage of active ingredient contained in such parenteral compositions is highly dependent on the specific nature ... The active materials can also be mixed with other active materials which do not impair the desired action, or with materials ...
  http://patents.com/us-9670198.html
*  Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine - Sepracor Inc.
... oral or parenteral (including intravenous injections or infusions). In preparing the compositions for oral dosage form any of ... The active compound of this composition and method is an optical isomer of the compound amlodipine, which is described in ... In describing an optically active compound, the prefixes D and L or R and S are used to denote the absolute configuration of ... The authors allege that in vitro evaluation of the enantiomers of amlodipine shows the (−) isomer to be twice as active as the ...
  http://www.freepatentsonline.com/6753338.html
*  Benzoxazepine compounds, their preparation and use - Patent # 8263587 - PatentGenius
... formulations of the present invention may be formulated for parenteral administration by injection or continuous infusion. ... An active compound would decrease the amount of glucose formed, which is read at 520 nm by glucose oxidase-peroxidase method.. ... Alternatively, the active ingredient may be in powder form for constitution with a suitable vehicle (e.g.,sterile, pyrogen-free ... The formulations according to the invention may contain between 0.1-99% of the active ingredient, conveniently from 30-95% for ...
  http://www.patentgenius.com/patent/8263587.html
*  A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
No active systemic infection requiring parenteral antibiotic therapy. - No history of or presence of a CNS disease. - No ... No major surgery or open biopsy within 28 days before drug infusion or evidence of. active bleeding postoperatively. - No plan ... non-aspirin NSAID within 48 hours following study treatment infusion. Other. - ...
  http://www.knowcancer.com/cancer-trials/NCT01325558/
*  Phenyl-pyridine/pyrazine amides for the treatment of cancer - Hoffmann-La Roche Inc.
Parenteral infusions include intramuscular, intravenous, intraarterial, intraperitoneal, or subcutaneous administration.. The ... A compound of formula I can be used in a manner known per se as the active ingredient for the production of tablets of the ... A compound of formula I can be used in a manner known per se as the active ingredient for the production of capsules of the ... Although Silibinin, the major active constituent of silymarin isolated from milk thistle (Silybum marianum), has shown strong ...
  http://www.freepatentsonline.com/9458106.html
*  Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia - Full Text View - ClinicalTrials.gov
parenteral analgesia combining acetaminophen and morphine. Active Comparator: 2 Patients with intravenous lidocaine infusion ... Drug: continuous ropivacaine preperitoneal infusion Drug: intravenous lidocaine infusion Drug: parenteral analgesia combining ... Drug: parenteral analgesia combining acetaminophen and morphine parenteral analgesia combining acetaminophen and morphine ... Drug: parenteral analgesia combining acetaminophen and morphine parenteral analgesia combining acetaminophen and morphine ...
  https://clinicaltrials.gov/ct2/show/NCT01077752
*  Hybrid oligomers, their preparation process and pharmaceutical compositions containing them - Patent # 8138145 -...
Compositions which are suitable for parenteral administration are aqueous solutions of an active ingredient in water-soluble ... Solutions such as are used, for example, for parental administration can also be used as infusion solutions. Preferred ... The active ingredient can also be present here in the form of a lyophilisate, if appropriate together with excipients, and be ... Some .beta.3-nonapeptides with a C-terminal amide were found to be active against Gram-Positive (S. Aureus and E. Faecium ...
  http://www.patentgenius.com/patent/8138145.html